Founded Year
1994Stage
Take Private | AliveTotal Raised
$13.15MAbout ZymeTx
ZymeTx is a biotechnology company that engages in the development of products for the diagnosis and treatment of viral disease, viral management, and disease surveillance. ViraZyme, its core technology, exploits the subtle structural differences and characteristics of enzymes to create products to diagnose and treat viruses. The company's diagnostic technology is a platform for proprietary two-part compounds that will split when the compound contacts a specific enzyme, which is the viral target site.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
ZymeTx Frequently Asked Questions (FAQ)
When was ZymeTx founded?
ZymeTx was founded in 1994.
Where is ZymeTx's headquarters?
ZymeTx's headquarters is located at 800 Research Parkway, Oklahoma City.
What is ZymeTx's latest funding round?
ZymeTx's latest funding round is Take Private.
How much did ZymeTx raise?
ZymeTx raised a total of $13.15M.
Who are the investors of ZymeTx?
Investors of ZymeTx include ZymeTx.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
